Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Experimental Neurology
|
July 1, 2014
Complement emerges as a masterful regulator of CNS homeostasis, neural synaptic plasticity and cognitive function
Dimitrios C Mastellos
Clinical Immunology (Orlando, Fla.)
|
October 29, 2020
Response to "Comment on Mastellos and colleagues and efficacy of complement-targeting drugs in COVID-19"
Dimitrios C Mastellos, John D Lambris
Nature Immunology
|
April 4, 2025
'Complement-ing' tissue inflammation via granzyme K?
Dimitrios C Mastellos, John D Lambris
Seminars in Immunology
|
August 1, 2022
Recent developments in C3-targeted complement therapeutics
Dimitrios C Mastellos, John D Lambris
Trends in Pharmacological Sciences
|
October 30, 2024
Pegcetacoplan (Syfovre<sup>ΤΜ</sup>): targeting complement C3 in geographic atrophy
Dimitrios C Mastellos, John D Lambris
Frontiers in Immunology
|
March 21, 2019
Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
Eleni Gavriilaki, Achilles Anagnostopoulos, Dimitrios C Mastellos
Nature Reviews. Immunology
|
September 5, 2023
A guide to complement biology, pathology and therapeutic opportunity
Dimitrios C Mastellos, George Hajishengallis, John D Lambris
Nature Reviews. Drug Discovery
|
December 11, 2019
Therapeutic targeting of the complement system
Daniel Ricklin, Dimitrios C Mastellos, John D Lambris
Clinical Immunology (Orlando, Fla.)
|
June 20, 2021
From discovery to approval: A brief history of the compstatin family of complement C3 inhibitors
Dimitrios C Mastellos, Daniel Ricklin, Georgia Sfyroera, et al.
The Journal of Clinical Investigation
|
May 4, 2021
Is complement the culprit behind COVID-19 vaccine-related adverse reactions?
Dimitrios C Mastellos, Panagiotis Skendros, John D Lambris
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Experimental Neurology
|
July 1, 2014
Complement emerges as a masterful regulator of CNS homeostasis, neural synaptic plasticity and cognitive function
Dimitrios C Mastellos
Clinical Immunology (Orlando, Fla.)
|
October 29, 2020
Response to "Comment on Mastellos and colleagues and efficacy of complement-targeting drugs in COVID-19"
Dimitrios C Mastellos, John D Lambris
Nature Immunology
|
April 4, 2025
'Complement-ing' tissue inflammation via granzyme K?
Dimitrios C Mastellos, John D Lambris
Seminars in Immunology
|
August 1, 2022
Recent developments in C3-targeted complement therapeutics
Dimitrios C Mastellos, John D Lambris
Trends in Pharmacological Sciences
|
October 30, 2024
Pegcetacoplan (Syfovre<sup>ΤΜ</sup>): targeting complement C3 in geographic atrophy
Dimitrios C Mastellos, John D Lambris
Frontiers in Immunology
|
March 21, 2019
Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
Eleni Gavriilaki, Achilles Anagnostopoulos, Dimitrios C Mastellos
Nature Reviews. Immunology
|
September 5, 2023
A guide to complement biology, pathology and therapeutic opportunity
Dimitrios C Mastellos, George Hajishengallis, John D Lambris
Nature Reviews. Drug Discovery
|
December 11, 2019
Therapeutic targeting of the complement system
Daniel Ricklin, Dimitrios C Mastellos, John D Lambris
Clinical Immunology (Orlando, Fla.)
|
June 20, 2021
From discovery to approval: A brief history of the compstatin family of complement C3 inhibitors
Dimitrios C Mastellos, Daniel Ricklin, Georgia Sfyroera, et al.
The Journal of Clinical Investigation
|
May 4, 2021
Is complement the culprit behind COVID-19 vaccine-related adverse reactions?
Dimitrios C Mastellos, Panagiotis Skendros, John D Lambris
Page
of 6